STEVENS CAPITAL MANAGEMENT LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$33,000
-15.4%
15,859
+23.8%
0.00%
-50.0%
Q4 2015$39,000
+5.4%
12,814
-14.6%
0.00%0.0%
Q3 2015$37,000
-28.8%
15,003
-7.6%
0.00%0.0%
Q2 2015$52,0000.0%16,242
-39.7%
0.00%0.0%
Q3 2014$52,00026,9370.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders